Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2008-12-22
2011-11-22
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S248000, C544S232000, C544S236000
Reexamination Certificate
active
08063028
ABSTRACT:
Compounds of formula I, wherein R1, R2, R3, X1, X2and Ar, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula I useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.
REFERENCES:
patent: 7166738 (2007-01-01), Dunn et al.
patent: 7189718 (2007-03-01), Dunn et al.
patent: 7208509 (2007-04-01), Dunn et al.
patent: 7241794 (2007-07-01), Dunn et al.
patent: 2005/0215554 (2005-09-01), Dunn et al.
patent: 2005/0239880 (2005-10-01), Dunn et al.
patent: 2006/0025462 (2006-02-01), Dunn et al.
patent: 2006/0069261 (2006-03-01), Bonneau et al.
patent: 2006/0223874 (2006-10-01), Martin et al.
patent: 2007/0021442 (2007-01-01), Saggar et al.
patent: 2007/0078128 (2007-04-01), Saito et al.
patent: 2007/0088015 (2007-04-01), Silva et al.
patent: 2007/0088053 (2007-04-01), Mirzadegan et al.
patent: 2011/0059975 (2011-03-01), Kennedy-Smith et al.
patent: 2011/0105496 (2011-05-01), Gamber et al.
patent: WO-02/04424 (2002-01-01), None
patent: WO-02/30907 (2002-04-01), None
patent: WO-02/085860 (2002-10-01), None
patent: WO-02/100853 (2002-12-01), None
patent: WO-2004/002951 (2004-01-01), None
patent: WO-2004/002951 (2004-01-01), None
patent: WO-2004/029042 (2004-04-01), None
patent: WO-2004/031156 (2004-04-01), None
patent: WO-2004/031178 (2004-04-01), None
patent: WO-2006/067587 (2006-06-01), None
patent: WO-2006/067589 (2006-06-01), None
Chan, J. H., et. al. “Novel Bensophenones as Non-Nucleoside Reverse Transcriptase Inhibitors of HIV-1,”Journal of Medicinal Chemistry, 2004, vol. 47, pp. 1175-1182.
Genin, M. J., et. al. “Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives,”Journal of Medicinal Chemistry, 2000, vol. 43, pp. 1034-1040.
Romines, K. R., et. al. “Structure—Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitors,”Journal of Medicinal Chemistry, 2006, vol. 49, pp. 727-739.
Wyatt, P. G., et. al. “Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,”Journal of Medicinal Chemistry, 1995, vol. 38, pp. 1657-1665.
Billedeau Roland Joseph
Sweeney Zachary Kevin
Buckwalter Brian L.
Jaisle Cecilia M
Roche Palo Alto LLC
Wilson James O
LandOfFree
Heterocyclic antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic antiviral compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4307282